newsfilter
← Latest News
GlobeNewswire·

Sagimet Biosciences Presents Two Denifanstat Posters at AASLD—The Liver Meeting® 2025

A secondary analysis of FASCINATE-2 Phase 2 trial demonstrated denifanstat improved fibrosis, inflammation and steatosis in advanced qF4 MASH patients as measured by artificial intelligence (AI) digital pathology In a